Commentary on: Loberg M, Kalager M, Holme O, et al. Longterm colorectal-cancer mortality after adenoma removal. N Engl J Med 2014;371:799-807.
ContextThe association of colorectal cancer (CRC) with pre-existing adenomatous polyps was challenged for decades until the National Polyp Study (NPS) demonstrated that colonoscopic polypectomy prevented deaths from CRC. 1 In a follow-up of the Minnesota Colon Cancer Control study (46 551 participants), those randomly assigned to annual screening with a sensitive faecal occult blood test, sustained a 32% CRC mortality reduction over 30 years which was consistent with the effect of polypectomy. 2 In the Nurses' Health Study and the Health Professional Follow-up Study (88 902 participants followed over 22 years), lower endoscopy was associated with a 43% CRC mortality reduction compared to no endoscopy. 3
MethodsLoberg and colleagues reported a study in which they linked the Norwegian Cancer Registry and the Cause of Death Registry to estimate the cause of death in 40 826 patients in whom colorectal adenomas were removed compared to what was expected in the general population. Standardised mortality ratios (SMR) were calculated comparing expected to observed deaths.
FindingsDuring a median of 7.7 years of follow-up, no CRC mortality reduction in the entire cohort (SMR 0.96, 95% CI 0.87 to 1.06) was observed. However, Loberg and colleagues did observe a mortality reduction in those with low-risk adenomas (SMR 0.75, 95% CI 0.63 to 0.88) but not in those with high-risk adenomas (SMR 1.16, 95% CI 1.02 to 1.31).
CommentaryIn contrast to this study, the NPS cohort, which consisted of 55% highrisk adenoma participants, observed a 53% mortality reduction compared to the US general population. The term 'high-risk adenomas' (advanced adenomas in other studies) has usually been applied to adenomas that have high-grade dysplasia, or are ≥1 cm in size, or have ≥25% villous components, or are ≥3 in number. 'Low-risk adenomas' (non-advanced adenomas) have none of these features. There is evidence that the risk for future high-risk adenomas and CRC is higher in patients having high-risk adenomas at initial colonoscopy. Most guidelines recommend stratifying postpolypectomy patients into low and high risk for longer (5-10 years) or shorter (3 years) surveillance intervals. 4 There are several possible explanations for the lack of CRC mortality reduction observed by Loberg and colleagues in patients with high-risk adenomas. Future CRC risk correlates with the initial colonoscopy quality benchmarks including: the rate of caecal intubation, adenoma detection rate, cleansing thoroughness and mean withdrawal time. Completeness of polypectomy, especially of large (high risk) adenomas that are often removed 'piece-meal', is also important to minimise subsequent (interval) CRC. Approximately 70% of interval CRC's are a result of either missed lesions or incomplete polypectomy. 4 It would be of interest if the authors could link their mortality data to colonoscopy performance. This information was not...